134 related articles for article (PubMed ID: 8542303)
1. MPTP- and MPP(+)-induced effects on body temperature exhibit age- and strain-dependence in mice.
Freyaldenhoven TE; Ali SF; Hart RW
Brain Res; 1995 Aug; 688(1-2):161-70. PubMed ID: 8542303
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity by deprenyl in organotypic canine substantia nigra cultures.
Schmidt DE; Ebert MH; Lynn JC; Whetsell WO
J Neural Transm (Vienna); 1997; 104(8-9):875-85. PubMed ID: 9451719
[TBL] [Abstract][Full Text] [Related]
3. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
Moy LY; Albers DS; Sonsalla PK
Brain Res; 1998 Apr; 790(1-2):264-9. PubMed ID: 9593931
[TBL] [Abstract][Full Text] [Related]
4. Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice.
Vaglini F; Fascetti F; Tedeschi D; Cavalletti M; Fornai F; Corsini GU
Neurodegeneration; 1996 Jun; 5(2):129-36. PubMed ID: 8819133
[TBL] [Abstract][Full Text] [Related]
5. Role of heat shock proteins in MPTP-induced neurotoxicity.
Freyaldenhoven TE; Ali SF
Ann N Y Acad Sci; 1997 Oct; 825():167-78. PubMed ID: 9369985
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens.
Wu WR; Zhu ZT; Zhu XZ
Life Sci; 2000 Jun; 67(3):241-50. PubMed ID: 10983868
[TBL] [Abstract][Full Text] [Related]
7. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
Zuddas A; Fascetti F; Corsini GU; Piccardi MP
Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
[TBL] [Abstract][Full Text] [Related]
8. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
9. Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B).
Ito T; Suzuki K; Uchida K; Nakayama H
Exp Toxicol Pathol; 2013 Jan; 65(1-2):153-8. PubMed ID: 21855308
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of a parkinsonism-inducing neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mouse body temperature.
Satoh N; Yonezawa A; Tadano T; Kisara K; Arai Y; Kinemuchi H
Life Sci; 1987 Sep; 41(11):1415-24. PubMed ID: 3498107
[TBL] [Abstract][Full Text] [Related]
11. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice.
Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK
J Pharmacol Exp Ther; 1991 May; 257(2):691-7. PubMed ID: 2033514
[TBL] [Abstract][Full Text] [Related]
12. The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression.
Hung HC; Lee EH
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):14-26. PubMed ID: 8883930
[TBL] [Abstract][Full Text] [Related]
13. Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatum.
Zuddas A; Corsini GU; Schinelli S; Barker JL; Kopin IJ; di Porzio U
Brain Res; 1989 Oct; 501(1):11-22. PubMed ID: 2804689
[TBL] [Abstract][Full Text] [Related]
14. Calcium channel agonist, (+/-)-Bay K8644, causes an immediate increase in the striatal 1-methyl-4-phenylpyridinium level following systemic administration of the dopaminergic neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in Balb/c mice.
Samantaray S; Mohanakumar KP
Neurosci Lett; 2003 Jul; 346(1-2):69-72. PubMed ID: 12850550
[TBL] [Abstract][Full Text] [Related]
15. Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mimicked by 1-methyl-4-phenylpyridinium (MPP+) and not blocked by deprenyl.
Fuller RW; Hemrick-Luecke SK
Life Sci; 1986 Nov; 39(18):1645-50. PubMed ID: 3095601
[TBL] [Abstract][Full Text] [Related]
16. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenylpiridinium (MPP(+)) converted from MPTP through MAO-B.
Ito T; Suzuki K; Uchida K; Nakayama H
Exp Toxicol Pathol; 2012 Nov; 64(7-8):761-5. PubMed ID: 21324658
[TBL] [Abstract][Full Text] [Related]
17. A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons.
Johannessen JN
Neurotoxicology; 1991; 12(2):285-302. PubMed ID: 1956587
[TBL] [Abstract][Full Text] [Related]
18. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
Fornai F; Alessandrì MG; Torracca MT; Bassi L; Corsini GU
J Pharmacol Exp Ther; 1997 Oct; 283(1):100-7. PubMed ID: 9336313
[TBL] [Abstract][Full Text] [Related]
19. Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones.
Wüllner U; Löschmann PA; Schulz JB; Schmid A; Dringen R; Eblen F; Turski L; Klockgether T
Neuroreport; 1996 Mar; 7(4):921-3. PubMed ID: 8724674
[TBL] [Abstract][Full Text] [Related]
20. Neuronal protective and rescue effects of deprenyl against MPP+ dopaminergic toxicity.
Wu RM; Murphy DL; Chiueh CC
J Neural Transm Gen Sect; 1995; 100(1):53-61. PubMed ID: 8748663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
